In healthy men, these antigens are frequently and almost exclusively expressed in the prostate [15–18], and overexpressed in prostate cancer; with the exception of PSMA which is also overexpressed in the tumor-neovasculature of other cancers [15, 19]. This evidence concerns the gene FOLH1 and prostate carcinoma.